Free shipping on all orders over $ 500

BAY-60-7550

Cat. No. M1734
BAY-60-7550 Structure
Size Price Availability Quantity
10mg USD 420 In stock
50mg USD 900 In stock
Bulk Inquiry?

Quality Control
Biological Activity

BAY-60-7550 is a potent Type 2 cyclic nucleotide phosphodiesterases (PDE2) inhibitor with IC50 values of 2.0 nM (bovine) and 4.7 nM (human). BAY-60-7550 is an analog of EHNA, which is more than 100-fold more potent and is highly selective for PDE2A.

Protocol
Cell Experiment
Cell lines human distal pulmonary artery smooth muscle cells
Preparation method Cell proliferation.
Growth of human distal pulmonary artery smooth muscle cells isolated from patients with idiopathic pulmonary arterial hypertension (IPAH) or control cells from adults undergoing transplant or lung resection for suspected malignancy, were monitored as we have described previously 29 following treatment with BAY 60-7550 (1μmol/L), ANP (1μmol/L), DETA-NONOate (10μmol/L), or treprostinil (1μmol/L), alone or in combination.
Concentrations 1μmol/L
Incubation time unknow
Animal Experiment
Animal models Oxidative Stress on Behavior in mice
Formulation dissolved in 50% dimethyl sulfoxide (Fisher Scientific Co., Pittsburgh, PA)
Dosages 3 mg/kg; given 30 min before each BSO treatment
Administration i.p.
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of resveratrol used for a mouse (22.4 mg/kg) to a dose based on the BSA for a rat, multiply 22.4 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for resveratrol of 11.2 mg/kg.

Chemical Information
Molecular Weight 476.57
Formula C27H32N4O4
CAS Number 439083-90-6
Purity >99%
Solubility DMSO
Storage at -20°C
References

Inhibition of phosphodiesterase 2 augments cGMP and cAMP signaling to ameliorate pulmonary hypertension.
Bubb KJ, et al. Circulation. 2014 Aug 5;130(6):496-507. PMID: 24899690.

Phosphodiesterase-2 inhibitor reverses corticosterone-induced neurotoxicity and related behavioural changes via cGMP/PKG dependent pathway.
Xu et al. Int J Neuropsychopharmacol. 2012 Jul 31;1-13. PMID: 22850435.

Mechanisms of carbon monoxide attenuation of tubuloglomerular feedback.
Ren et al. Hypertension. 2012 Jun;59(6):1139-44. PMID: 22508834.

Selective phosphodiesterase inhibitors improve performance on the ED/ID cognitive task in rats
Rodefer et al. Neuropharmacology. 2012 Mar;62(3):1182-90. PMID: 21856317.

PDE5A suppression of acute beta-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation.
Lee et al. Basic Res Cardiol. 2010 May;105(3):337-47. PMID: 20107996.

Reversal of oxidative stress-induced anxiety by inhibition of phosphodiesterase-2 in mice.
Masood A, et al. J Pharmacol Exp Ther. 2008 Aug;326(2):369-79. PMID: 18456873.

Related PDE Products
E6005

RVT-501 (E6005) is a selective phosphodiesterase 4 (PDE4PDE4) inhibitor with an IC50 of 2.8 nM.

Vardenafil HCl

Vardenafil Hcl is a PDE5 inhibitor used for treating erectile dysfunction.

Udenafil

Udenafil(DA8159) is a PDE5 inhibitor used in urology to treat erectile dysfunction.

Theophylline

Theophylline is a methylated xanthine derivative; competitive nonselective phosphodiesterase inhibitor and nonselective adenosine receptor antagonist.

Sildenafil Mesylate

Sildenafil Mesylate is a mesylate form of Sildenafil, an inhibitor of Phosphodiesterase 5.

  Catalog
Abmole Inhibitor Catalog 2017




Keywords: BAY-60-7550 supplier, PDE, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.